Bharat Serums & Vaccines (BSV) is a niche biological and bio-pharmaceutical products manufacturer. The company, is a formidable domestic player in plasma derivatives, equine antitoxins, immunoglobulin serums and hormones. The company has several first launches to it's credit which include Anti D Immuno Globulin a monoclonal antibody developed for the first time globally, liquid stable anti snake venom effective against all poisonous snakes commonly found in Asia & Africa, Amphotericin B Lipid Complex, Anti Thymocyte Globulin and Profofol Emulsion among others.
The Mumbai based company has a strong portfolio of niche primary line, life saving injectables for snake bites, rabies, aplastic anemia, meningitis, kala azar, postpartum hemorrhage, and life threatening fungal infections post surgeries and organ transplants. BSV also enjoys good brand equity in the critical area of Infertility with its portfolio of hormones.
BSV is expanding through development and launch of new generation biotech recombinant therapeutic proteins, monoclonal antibodies, difficult generics and Novel Drug Delivery Systems where it is in the process of seeking out licensing opportunities for the global markets. Some of these products ready for out-licensing deals include Liposomal Amphoterecin B a potent anti-fungal agent for serious and life-threatening infections, Pegylated Liposomal Doxorubicin a potent anthracycline-based cytotoxic agent for the treatment of cancer, Goserelin Implants and Leuprolide Injection both indicated for hormone sensitive malignancies and gynecological indications and Recombinant Follicle Stimulating Hormone (FSH) used to induce ovulation and spermatogenesis.
Global investors are betting big on India�s long-term growth story.India istoday one of the most attractive emerging markets across Asia with a billion plus captive consumers. Kotak Private Equity is well positioned to develop compelling local investing themes.
Through macro research, in-house analytics and frequent industry interactions, we identify industry and socio-economic trends, local consumption patterns and need-gap opportunities on an ongoing basis. With a cumulative experience of successfully investing in over 100 growth companies, we regularly refine our investment focus based on emerging trends, sectors and investment opportunities.
Our team�s past investments include backing some of India�s most successful entrepreneurs across many of the sectors mentioned above.
At Kotak Private Equity, we believe in partnering with companies, not operating them. We partner to accelerate growth through need based strategic value-addition in a variety of ways. In addition to capital, we bring our expertise, experience and commitment to create a shared vision and value.
We believe that we can never substitute an entrepreneur�s energy, passion and drive. Hence, at Kotak Private Equity, we like to complement these skills with strategic growth advice, skill enhancement and operational efficiency to disproportionally deliver on his business plan.
At Kotak Private Equity, we follow an investment process that has been developed through years of investment experience. The investment process captures the sensitivities and challenges of growing businesses in an Indian business environment as well our past experiences in dealing with Indian entrepreneurs.
Since its inception,Kotak Private Equity has been the preferred investment partner with local management teams on account of its transparent and rigorous investment process, significant value creation and strategic and timely exit.
We design bespoke investment structures for each of ourportfolio companies based on theirindividual growth requirements. We believe in patient investing through structured instrumentsthat help build partnerships with management teamsanddeliver on mutually aligned goals and incentives.